BLLN
BillionToOne, Inc.
$127.97
+7.37 (+6.11%)
At close · Jul 9
Market Cap
$5.83B
Shares
45,995,484
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$305.11M
FY2025
Net Income
$7.45M
FY2025
Gross Margin
68.32%
FY2025
Operating Margin
5.25%
FY2025
Diluted EPS
$0.14
FY2025
Operating Cash Flow
$24.6M
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | FY2025 |
|---|---|---|
| $450M – $465M | $305.11M | |
| — | $96.65M | |
| — | $208.46M | |
| — | 68.32% | |
| — | $49.38M | |
| — | $143.05M | |
| — | $6.9M | |
| — | $192.44M | |
| — | $16.02M | |
| — | 5.25% | |
| — | $22.92M | |
| — | $95K | |
| — | $7.75M | |
| — | -$8.26M | |
| — | $7.76M | |
| — | $305K | |
| — | $7.45M | |
| — | 2.44% | |
| — | $2.92M | |
| — | $5.66M | |
| USD/shares | — | $0.18 |
| USD/shares | — | $0.14 |
| shares | — | 15.88M |
| shares | — | 21.23M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
(G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Prenatal | $277,105,000 | $145,901,000 | $68,803,000 |
| Oncology | $24,953,000 | $2,944,000 | $0 |
| Clinical Trial Support and Other Services | $3,054,000 | $3,737,000 | $2,926,000 |